Minocycline for symptom reduction during radiation therapy for head and neck cancer: a randomized clinical trial

PURPOSE: Local/systemic symptoms during cancer therapy may be exacerbated by dysregulated inflammation and its downstream toxic effects. Minocycline can suppress proinflammatory cytokine release; therefore, we investigated its potential to reduce patient-reported symptom severity during radiotherapy...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Support Care Cancer
Main Authors: Gunn, G. Brandon, Mendoza, Tito R., Garden, Adam S., Wang, Xin Shelley, Shi, Qiuling, Morrison, William H., Frank, Steven J., Phan, Jack, Fuller, Clifton D., Chambers, Mark S., Hanna, Ehab Y., Lu, Charles, Rosenthal, David I., Cleeland, Charles S.
Formato: Artigo
Idioma:Inglês
Publicado: 2019
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7470188/
https://ncbi.nlm.nih.gov/pubmed/31037378
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00520-019-04791-4
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares